[1]
“Chronic kidney disease in adults with primary immunodeficiency diseases in treatment with intravenous immunoglobulin”, Rev Alerg Mex, vol. 67, no. 1, pp. 25–33, Jan. 2020, doi: 10.29262/ram.v67i1.707.